News

FDA issues highest risk warning for vegetable recall
And Go Concepts LLC announced a voluntary recall for a range of vegetable products on May 27 due to potential listeria ...
FDA Approves Gardenia-Based Blue Dye for Use in Foods and Drinks
TUESDAY, July 15, 2025 (HealthDay News) — A natural blue food coloring made from gardenia fruit has been approved by the U.S.
FDA panel to revisit menopausal hormone therapy
MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...
FDA warns companies over ingredient in gas station opioid alternatives
Kratom, made from the leaves of a tropical tree called Mitragyna speciosa that is native to Southeast Asia, contains two main ...
FDA staff raises eye damage concerns for GSK's blood cancer drug
The U.S. Food and Drug Administration's staff reviewers on Tuesday raised safety concerns that GSK's blood cancer drug ...
FDA approves gardenia blue for foods as ice cream industry may move to drop artificial dyes
The U.S. Food and Drug Administration has granted use the color gardenia (genipin) blue in various foods. Additionally, ice ...
Explore more
ConsumerAffairs2h
Consumer coalition wants stronger FDA front-of-package labels
Coalition Urges Stronger FDA Front-of-Package Labels on Sugars, Sodium, Fats 28 consumer and health groups plus 12 ...
FDA adds new blue food dye from gardenia fruit
The U.S. Food and Drug Administration on Monday approved the use of a new blue color additive from the gardenia fruit the ...
BioSpace7h
FDA Commissioner Marty Makary Proposes Lowering Industry User Fees
According to Makary, reducing user fees—which make up just under half of the FDA's budget—could make it easier for smaller ...
MPR2h
FDA to Review Arexvy for 18 to 49-Year-Olds at Increased RSV Disease Risk
Arexvy is currently approved to prevent lower respiratory tract disease (LRTD) caused by RSV in individuals aged 60 years and older, and those 50 to 59 years of age who are at increased risk for LRTD ...
FDA flags safety concerns related to GSK’s blood cancer drug ahead of AdCom meeting
GSK (GSK) stock in focus as the FDA staff raise safety concerns over Blenrep combo for multiple myeloma ahead of an AdCom ...
STAT3h
A troubled Sun Pharma plant fails yet another FDA inspection
A Sun Pharmaceutical plant in India that has been repeatedly cited by the FDA for serious quality control issues failed another inspection last month.